|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.94 USD | +1.56% |
|
+5.06% | +39.63% |
| May. 31 | Piper Sandler Initiates Immunome With Overweight Rating, $27 Price Target | MT |
| May. 21 | Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing | MT |
Immunome, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 129.49 million compared to USD 4.27 million a year ago. Basic loss per share from continuing operations was USD 2.51 compared to USD 0.35 a year ago.
Diluted loss per share from continuing operations was USD 2.51 compared to USD 0.35 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +39.63% | 896M | |
| +11.91% | 118B | |
| +11.60% | 106B | |
| -4.68% | 24.28B | |
| -0.82% | 21.96B | |
| -10.12% | 18.16B | |
| -42.12% | 16.37B | |
| -17.47% | 15.56B | |
| +2.77% | 13.63B | |
| +34.58% | 12.27B |
IMMUNOME, INC. 
